Cytogenetic and Molecular Changes in Leukemia Found. among Atomic Bomb Survivors
|
|
- Wilfred Barrett
- 5 years ago
- Views:
Transcription
1 A Review of Forty-Five Years Study of Hiroshima and Nagasaki Atomic Bomb Survivors II. BIOLOGICAL EFFECTS Cytogenetic and Molecular Changes in Leukemia Found among Atomic Bomb Survivors NANAO KAMADA Department of Hematology, Research Institute for Nuclear Medicine and Biology, Hiroshima University, Hiroshima 734, Japan Chromosome aberrations/leukemia/atomic bomb survivors/bcr-gene/ras-gene Seventy five radiation-related leukemias (acute non-lymphocyte) in Hiroshima including 16 patients exposed to more than one Gray were cytogenetically examined. Statistical analysis of the data on the frequencies of chromosomal aberrations in survivors according to the bone marrow doses of DS86 estimation revealed that heavily exposed patients tended to have significantly higher aberration rates as compared with non-exposed patients. Furthermore, the chromosomal aberrations in the survivors were observed to be of a more complex nature and had characteristic findings of secondary leukemia. These observations therefore suggest that patients with a history of heavy exposure to atomic bomb radiation exhibit leukemic cells that originated from a stem cell which had been damaged by irradiation at the time of bombing and had been involved in the complex chromosome abnormalities. Molecular biological studies on transforming genes in acute and chronic leukemia and the bcr gene in chronic myelocytic leukemia have been performed in exposed and non-exposed groups. So far, no distinctive differences have been observed in the frequency and the sites of point mutations in N and K-ras genes or in the rearrangement of the bcr gene, for a final conclusion of the specificity of radiation induced leukemia. Further retrospective studies require patient DNAs that developed in the early period of the atomic bomb exposure. INTRODUCTION It has been shown") that the incidence of leukemia is high among atomic bomb survivors. Since the first report by Ford 5) on human chromosomes in leukemia, many reports have been presented. The relation between radiation and chromosome aberration is a very interesting problem from the view point of the leukemogenic mechanism. In this presentation, chromosome abnormalities and molecular biological changes found in leukemia patients with a history of atomic bomb exposure are reviewed in comparison with the findings in non-exposed leukemia patients. 1. Cytogenetic Changes i. Acute Leukemia There are a number of reports on chromosome studies of peripheral blood from apparently
2 healthy A-bomb survivors 6-9). It has been demonstrated that radiation-induced chromosome aberrations have persisted in the circulating lymphocytes of survivors more than three decades after radiation exposure, and that the chromosome-aberration frequency is, in general, proportional to the dose received. A high incidence of chromosome abnormalities of bone marrow cells has also been demonstrated in survivors with heavy exposure but without any hematological disorders at the time of examination. Chromosome aberration rates among bone marrow cells and T and B lymphocytes were found to be almost the same10). Kamada et al. have demonstrated annual changes of abnormal clones, representing the evidence that one abnormal clone after another showed dominant changes during several years, and have speculated that more active and more malignant clones leading to leukemia would appear in the bone marrow1 The first report on chromosome aberrations in acute leukemia among atomic bomb survivors in Hiroshima appeared in ). Kamada conducted chromosome studies on acute leukemia patients with a history of atomic bomb exposure and observed six abnormal karyotypes in ten exposed cases as well as ten abnormalities in 26 non-exposed cases. The type of chromosome aberrations varied between cases. No abnormal karyotypes characteristic of acute leukemia were observed in the exposed group. He extended his observations to 47 acute leukemia cases directly exposed to the atomic bomb and found 12 of 13 leukemia patients exposed within 1 km had abnormal clones in their bone marrow, showing a higher incidence of abnormal clones (92.3%) than the non-exposed group ( ) in 238 leukemia patients. According to his recent results 12) including 76 cases with a history of exposure analysed by radiation doses, some interesting findings were found among the exposed group. That is, patients who had been exposed to more than one Gray of bone marrow dose (DS86 dosimetry system) demonstrated a significantly higher incidence of chromosome aberrations in the leukemic cells. They had more complex types of chromosome aberrations and a higher incidence of aberrations in chromosomes 5 or 7, as compared with 261 non-exposed patients (Table 1). Concerning chromosome abnormalities of leukemias found in Nagasaki survivors, Tomonaga et al. 13,14) reported ten cases exposed within 4 km from the hypocenter, in which two patients who were exposed within 1.2 km had chromosome abnormalities. Though the number of cases examined in Nagasaki is smaller, leukemia patients with a history of heavy exposure seem to have a higher incidence of chromosome abnormalities. The reasons why acute leukemia patients with a history of heavy exposure manifest more complex chromosome aberrations in their leukemia cells is obscure. However, the previously mentioned findings in healthy survivors with a history of heavy exposure who have a high incidence of chromosome aberrations in bone marrow cells may give some suggestions. There is the possibility that the leukemic cells originated from a stem cell which had been damaged by irradiation at the time of bombing and was involved in the complex chromosome abnormalities. Abnormalities in chromosomes 5 and 7 were frequently reported in myelodysplastic syndrome and secondary leukemia 15-11) A high frequency of abnormalities in chromosomes 5 and 7 among leukemias in heavily exposed survivors indicates that leukemias induced by atomic bomb exposure have the same cytogenetic characteristics found in secondary leukemia induced by therapeutic irradiation or chemical drugs for cancer treatments.
3 Table 1. Chromosome aberrations in acute non-lymphocytic leukemia found among atomic bomb survivors 1) leukemia patients born before August 5, ) statistically significant (p< 0.001), compared with the controls. 3) statistically significant (p<0.05), compared with other groups. 4) statistically significant (p<0.01), compared with other groups. 5) bone marrow dose by means of DS86 dosimetry system given by RERF12). ii. Chronic Myelocytic Leukemia In 1963, Tanaka et al.19) first reported a case with a history of atomic bomb exposure and with the Philadelphia chromosome which is specific for the disease. Kinugasa et al.20) reported a case which developed 11 years after the exposure to atomic bomb and showed of cell with Ph' chromosomes and hyperdiploidy in the blastic phase. Tough 21) made a comparison on the clinical and hematological findings, survival time and cytogenetic findings between 8 cases of CML who had received X-ray treatment for ankylosing spondylitis and some cases without any radiation history and noted that for the first three above items there was no difference whatsoever between groups, and also that there was no decisive difference between the groups with regard to chromosome findings. In 1969 Kamada" described clinical and cytogenetic findings of six A-bomb exposed and 8 non-exposed patients with CML. Tsuchimoto et al.22) reported chromosome, clinical and hematological findings in 27 patients with CML, comparing 12 atomic-bomb survivors with 15 non-exposed patients. Ph' chromosomes were found in marrow cells from 14 patients with a frequency ranging from 62 to 100 per cent of the leukemic cells. No difference was observed cytogenetically between the atomic bomb and non-exposed groups. Kamada et al. extended their observations to 36 cases directly exposed to the atomic bomb, compared with 111 non-exposed cases 23). All cases, irrespective of atomic-bomb exposure, showed Ph' chromosome. There was no statistical difference in the incidence of the cases with
4 Table 2. Point mutation of N and K-ras genes in exposed and non-exposed groups * a double mutation in single case. additional chromosome abnormalities at the time of diagnosis of chronic phase of the disease (Table 2). Tomonaga13) and Sadamori et al.14) reported 6 exposed and 112 non-exposed cases in Nagasaki. All patients in the exposed and 97% of patients in the non-exposed group had Phl chromosomes with no statistical difference between the two groups. So far no cytogenetic differences in CML were found among the radiation exposed cases from either Hiroshima or Nagasaki. 2. Molecular Changes i. Transforming genes in acute and chronic leukemias The molecular genetic analysis of tumor development has been made possible by a combination of rapid technical progress in molecular biology and the fusion of ideas and perspectives from the fields of virology and chemical carcinogenesis. One of the most exciting developments has been the demonstration that proto-oncogenes exist in mutated or activated forms in non-virus-infected cells transformed by chemicals or isolated from human tumors24-26). It was shown that purified DNA from many tumors but not from equivalent normal tissues, could cause morphological transformation of recipient NIH/3T3 cells. In the vast majority of cases, the gene responsible for the transforming properties of DNA from tumors is a member of the ras family of proto-oncogenes. Three different members of the ras gene family have been identified as biologically active transforming genes in neoplasm DNA: H-ras, K-ras, and N-ras27-30). These genes have been detected in many different types of neoplasms, including carcinomas, sarcomas, lymphomas, and leukemias of myeloid and lymphoid origin. Thus, it appears that ras genes can contribute to the development of neoplasms. To clarify the mechanism of leukemia induced by radiation, the transforming activity of DNAs extracted from leukemic cells of acute and chronic leukemias of atomic bomb survivors was examined by the in vivo selection assay 31) and the polymerase chain reaction. N and K-ras gene mutations were detected in three acute and two chronic myelocytic leukemia patients in the exposed group. So far, no significant differences in the incidence of the mutated ras gene and
5 of the specific site of codons was observed between the exposed and non-exposed32). Guerrero I, et al. reported a consistent point mutation at codon 12 of the K-ras gene in radiation induced mouse lymphoma 33). Transforming ras genes have also been detected in rat mammary carcinomas induced by treatment with nitroso-methylurea34). In this case, a point mutation was found at codon 12 of H-ras gene, resulting in the replacement of glycine with glutamic acid in the p21 protein product. Further examination of point mutations in leukemias and cancers among survivors would be necessary for a final conclusion, using polymerase chain reaction (PCR) for specimens from malignant tissues which developed in the early period of atomic bomb exposure. ii. bcr gene in chronic myelocytic leukemia The Philadelphia chromosome detected in over 95% of patients with chronic myelocytic Fig. 1. Breakpoint of bcr gene in chronic myelocytic leukemia of exposed and non-exposed group. open circles: CML patients in exposed group solid circles: CML patients in non-exposed group
6 leukemia (CML) is generated by a reciprocal 9g34;22g11 translocation. This recombination event fuses a portion of chromosome 9 containing the entire c-abl gene to a region on chromosome 22 called the breakpoint cluster region (bcr)35). Tanaka et al.36) conducted molecular studies on seven CML patients with a history of atomic bomb exposure in comparison with 14 non-exposed CML patients. All patients, irrespective of radiation exposure, had rearrangements of the bcr gene in the leukemic cells. Further analysis of break points within the bcr gene demonstrated no distinct difference between the exposed and the non-exposed groups (Figure 1). They examined CML patients exposed within 2 km who developed CML in the 1980's, years after exposure. Most atomic bomb-related CML had developed by Again, as in the transforming gene, retrospective study is required for a final conclusion. REFERENCES 1. Heyssel, P.M., Brill, A.B., Woodbury, L.A., Nishimura, E.T., Ghose, T., Hoshino, T. and Yamasaki, M. (1960) Leukemia in Hiroshima atomic bomb survivors. Blood 15: Tomonaga, M. (1962) Leukemia in Nagasaki atomic bomb survivors from 1945 through Bull. Org. Mond. Sante. Bull. Wld. Hlth. Org. 26: Ichimaru, M. and Ishimaru, T. (1975) Leukemia and related disorders. II. Biological effects. J. Radiat. Res. (Supplement): Shimizu, Y., Kato, H. and Schull, W.J. (1988) Life Span Study Report 11, Part 2, Cancer mortality in the years based on the recently revised doses (DS86). Technical Report RERF TR Ford, C.E., Jacobs, P.A. and Lajtha, L.G. (1958) Human somatic chromosomes. Nature 181: Bloom, A.D., Neriishi, S., Kamada, N., Iseki, T. and Keehn, R.J. (1966) Cytogenetic investigation of survivors of the atomic bombings of Hiroshima and Nagasaki. Lancet ii: Awa, A.A., Neriishi, S., Honda, T., Yoshida, M.C., Sofuni, T. and Matsui, T. (1971) Chromosome aberration frequency in cultured blood cells in relation to radiation dose of A-bomb survivors. Lancet ii: Awa, A.A. (1988) Chromosomal aberrations in Atomic Bomb survivors. GANN Monograph on Cancer Research 35: Awa, A.A. (1975) Chromosome aberrations in somatic cells. Review of Thirty Years of Study of Hiroshima and Nagasaki Atomic Bomb Survivors. J. Radiat. Res. (Supplement): Kamada, N. and Tanaka, K. (1983) Cytogenetic studies of hematological disorders 1 in atomic bomb survivors. eds. by T. Ishihara and M. Sasaki. In: Radiation-Induced Chromosome Damage in Man. pp , Alan R. Liss, New York. 11. Kamada, N. (1969) The effects of radiation on chromosomes of bone marrow cells. III. Cytogenetic studies on leukemia in atomic bomb survivors. Acta Haematol. Jpn. 32: Kamada, N., Oguma, N., Tanaka, K., Takimoto, Y., Kuramoto, A., Kyo, T., Dohy, H., Mabuchi, K. and Kusumi, S. Cytogenetic studied on acute leukemia found among atomic bomb survivors with special reference to radiation doses. Radiation Effects Research Foundation Technical Report (in preparation). 13. Tomonaga, Y., Sadamori, N., Tagawa, M., Kusano, M., Nishio, K., Yao, E. and Ichimaru, M. Cytogenetic studies on leukemia and preleukemia in atomic bomb survivors - Structural abnormalities of chromosomes as leukemia inducing factors (further report) Sadamori, N., Tomonaga, Y., Tagawa, M., Kusano, M., Nishio, K., Yao, E. and Ichimaru, M. Cytogenetic studies on leukemia and preleukemic state in atomic bomb survivors -Structural abnormality of chromosomes as leukemia inducing factors (preliminary report) Rowley, J.D., Golomb, H.M. and Vardiman, J. (1977) Nonrandom chromosomal abnormalities in acute non-lymphocytic leukemia in patients treated for Hodgkin's disease and non-hodgkin lymphomas. Blood 50:
7 16. Le Beau, M.M., Albain, K.S., Larson, R.A., Vardiman, J.W., Davis, E.M., Blough, R.R., Golomb, H.M. and Rowley, J.D. (1986) Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes No. 5 and 7. J. Clin. Oncol. 4: Pedersen-Bjergaard, J. and Philip, P. (1987) Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia and acute myelo-proliferative syndrome: correlation with clinical data for 61 consecutive cases. Br. J. Haematol. 66: Whang-Peng, J., Young, R.C., Lee, E.C., Longo, D.L., Schechter, G.P. and DeVita, Jr. V.T. (1988) Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different therapy modalities. Blood 71: Tanaka, N., Ito, K., Kamada, N. and Okada, K. (1963) A case of atomic bomb survivors with chronic granulocytic leukemia in early stage. J. Kyushu Haematol. Soc. 13: Kinugasa, K. (1966) Chromosome constitution of leukemia cells. Jpn. J. Clin. Haematol. 7: Tough, I.M. (1965) Cytogenetic studies in cases of chronic myelocytic leukemia with a previous history of radiation. In: Current Research in Leukemia. eds. by F.G.J. Hayhoe, Cambridge University press, pp Tsuchimoto, T., Kamada, N., Ishii, Y., Ozono, N. and Uchino, H. (1970) A study of chronic granulocytic leukemia with special reference to A-bomb survivors. Proc. Hiroshima Univ. RINMB 11: Kamada, N., Tanaka, K., Dohy, H., Takimoto, Y., Oguma, N. and Kuramoto, A. (1984) Cytogenetic studies on patients with leukemia and RAEB found in atomic bomb survivors. Jpn. J. Clin. Hematol. 25: Reddy, E.P., Reynolds, R.K., Santos, E. and Barbacid, M. (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300: Tabin, C.J., Bradley, S.M., Bargmann, C.I., et al. (1982) Mechanism of activation of a human oncogene. Nature 300: Taparowsky, E., Suard, Y., Fasano, 0., Shimizu, K., Goldfarb, M. and Wigler, M. (1982) Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300: Der, C.J., Krontiris, T.G. and Cooper, G.M. (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of harvey and Kirsten sarcoma viruses. Proc. Natl. Acad. Sci. USA 79: Hall, A., Marshall, C.J., Spurr, N.K. and Weiss, R.A. (1983) Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature 303: Parada, L.F., Tabin, C.J., Shih, C. and Weinberg, R.A. (1982) Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297: Santos, E., Tronick, S.R., Aaronson, S.A., Pulciani, S. and Barbacid, M. (1982) T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB and Harvey-MSV transforming genes. Nature 298: Southern, D.J. and Berg, P. (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promotion. J. Molecular Appl. Genet. 1: Tanaka, K. and Kamada, N. Ras gene mutation in leukemia patients with a history of A-bomb exposure (in preparation). 33. Guerrero, I., Villasante, A., Corces, V. and Pellicer, A. (1984) Activation of a c-k-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation. Science 14: Sukumar, S., Notario, V., Martin-Zanca, D. and Barbacid, M. (1983) Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 306: de Klein, A., van Kessel, A.G., Grosveld, G., Bartram, C.R., Hagemeijer, A., Bootsma, D., Spurr, N.K., Heisterkamp, N., Groffen, J. and Stephenson, J. (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 300:
8 36. Tanaka, K., Takechi, M., Hong, J.H., Shigeta, C., Oguma, N., Kamada, N., Takimoto, Y., Kuramoto, A., Dohy, H. and Kyo, T. (1989) 9;22 translocation and bcr rearrangements in chronic myelocytic leukemia patients among atomic bomb survivors. J. Radiat. Res. 30:
Atomic Bomb and Leukemia ICHIMARU M., TOMONAGA M., AMENOMORI T. AND MATSUO T.
Atomic Bomb and Leukemia ICHIMARU M., TOMONAGA M., AMENOMORI T. AND MATSUO T. Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine, Nagasaki, Japan (Received December
More informationoncogene and point mutation of N-RAS oncogene in acute myelocytic leukaemias with double minute chromosomes. Leukaemia, 7(3): ,
Ссы лки 1. Bennett JM, et al.: Proposals for the classification of acute leukeamias. Br J Haematol 33:451-458,1976 2. The Non-Hodgkinis Lymphoma Pathologic Classification Projects: National Cancer Institute
More informationLeukemia: Lessons from the Japanese Experience
Leukemia: Lessons from the Japanese Experience STUART C. FINCH Cooper Hospital, Camden, New Jersey, USA Key Words. Leukemia. Japan Life Span Study Atomic bomb. Radiation ABSTRACT Probably more has been
More informationA Review of Forty-Five Years Study of Hiroshima and Nagasaki Atomic Bomb Survivors
A Review of Forty-Five Years Study of Hiroshima and Nagasaki Atomic Bomb Survivors II. BIOLOGICAL EFFECTS Persistent Chromosome Aberrations in the Somatic Cells of A-bomb Survivors, Hiroshima and Nagasaki
More informationHigh Incidence of Meningioma among Hiroshima Atomic Bomb Survivors
J. RADIAT. RES., 40, 49 57 (1999) High Incidence of Meningioma among Hiroshima Atomic Bomb Survivors TAKAHIRO SHINTANI 1 *, NORIHIKO HAYAKAWA 2, MASAHARU HOSHI 3, MASAYUKI SUMIDA 4, KAORU KURISU 4, SHUUICHI
More informationTitle 50 Years-Long Term Follow Up Study. Citation Acta medica Nagasakiensia. 1997, 42
NAOSITE: Nagasaki University's Ac Title Author(s) Atomic Bomb Irradiation-induced Leu 50 Years-Long Term Follow Up Study Tomonaga, Masao; Matsuo, Tatsuki; P Citation Acta medica Nagasakiensia. 1997, 42
More informationChapter 4 Cellular Oncogenes ~ 4.6 -
Chapter 4 Cellular Oncogenes - 4.2 ~ 4.6 - Many retroviruses carrying oncogenes have been found in chickens and mice However, attempts undertaken during the 1970s to isolate viruses from most types of
More informationActivation of cellular proto-oncogenes to oncogenes. How was active Ras identified?
Dominant Acting Oncogenes Eugene E. Marcantonio, M.D. Ph.D. Oncogenes are altered forms of normal cellular genes called proto-oncogenes that are involved in pathways regulating cell growth, differentiation,
More informationEpidemiological Studies on the Atomic-bomb Survivors (Handout)
Epidemiological Studies on the Atomic-bomb Survivors (Handout) Kotaro OZASA Department of Epidemiology Radiation Effects Research Foundation Hiroshima, JAPAN 1 Atomic-bombings in Hiroshima and Nagasaki
More informationWhat causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)
Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes
More informationMolecular Analysis of Rearrangements in Philadelphia (Ph 1 ) Chromosome-Positive Leukemia
Molecular Analysis of Rearrangements in Philadelphia (Ph 1 ) Chromosome-Positive Leukemia J.D. Rowley A. Introduction The close association of specific chromosome abnormalities with particular types of
More informationRisk Models for Radiationinduced
Risk Models for Radiationinduced Leukaemia Richard Wakeford Visiting Professor in Epidemiology, Dalton Nuclear Institute, The University of Manchester, UK (Richard.Wakeford@manchester.ac.uk) Measures of
More information( Compauson of the JJsefulness_and_CoSts of R.r.AhI Analysis yprcnc. Chromosome Analyse
GARY MOCKLI ( Compauson of the JJsefulness_and_CoSts of R.r.AhI Analysis yprcnc Chromosome Analyse S^cv"to^n^termine Wh6ther bcr'abi anai>'sis can be utilized to ^valua* 7hSf I?f.Cemin hematopoietic malignancies
More informationRadiation Health Effects
Radiation Health Effects Elena Buglova Incident and Emergency Centre Department of Nuclear Safety and Security Content Historical background Primary target for cell damage Deterministic effects Stochastic
More informationMPL W515L K mutation
MPL W515L K mutation BCR-ABL genotyping The exact chromosomal defect in Philadelphia chromosome is a translocation. Parts of two chromosomes, 9 and 22, switch places. The result is a fusion gene, created
More informationunknown pathology. Due to the limited amount of DNA available, some samples were assayed only by DNA transfection
Proc. Nail. Acad. Sci. USA Vol. 82, pp. 3849-3853, June 1985 Medical Sciences Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors (gene ampliflication/point mutation/cancer/dna
More informationRadiation Carcinogenesis
Radiation Carcinogenesis November 11, 2014 Dhyan Chandra, Ph.D. Pharmacology and Therapeutics Roswell Park Cancer Institute Email: dhyan.chandra@roswellpark.org Overview - History of radiation and radiation-induced
More informationTitle. CitationAnnals of Hematology, 82(9): Issue Date Doc URL. Rights. Type. File Information. major BCR/ABL
Title A case of myelodysplastic syndrome developed blastic major BCR/ABL Author(s)Onozawa, Masahiro; Fukuhara, Takashi; Takahata, Muts CitationAnnals of Hematology, 82(9): 593-595 Issue Date 2003-09 Doc
More informationThe issue of second malignancies. Risks associated with radiotherapy UCL
The issue of second malignancies Risks associated with radiotherapy Spinocellular carcinoma of a dentist's finger QuickTime et un module de décompression QuickTime et to CD sont requis pour visualiser
More informationJAK2 V617F analysis. Indication: monitoring of therapy
JAK2 V617F analysis BCR-ABL genotyping The exact chromosomal defect in Philadelphia chromosome is a translocation. Parts of two chromosomes, 9 and 22, switch places. The result is a fusion gene, created
More informationAN ESTIMATE OF THE DOUBLING DOSE OF IONIZING RADIATION FOR HUMANS
- 23 - AN ESTIMATE OF THE DOUBLING DOSE OF IONIZING RADIATION FOR HUMANS James V. Neel Department of Human Genetics University of Michigan Medical School Ann Arbor, Michigan 48109-0618 Since 1946 a continuing
More informationDetection of abl/bcr Fusion Gene in Patients Affected by Chronic Myeloid Leukaemia by Dual-Colour Interphase Fluorescence in situ Hybridisation
Journal of Sciences, Islamic Republic of Iran 15(4): 321-325 (2004) University of Tehran, ISSN 1016-1104 Detection of abl/bcr Fusion Gene in Patients Affected by Chronic Myeloid Leukaemia by Dual-Colour
More informationHumanitarian Impact of Nuclear Weapons Oslo, Norway, March 4-5, 2013 Working Session I Immediate Humanitarian impact of a nuclear weapon detonation
Humanitarian Impact of Nuclear Weapons Oslo, Norway, March 4-5, 2013 Working Session I Immediate Humanitarian impact of a nuclear weapon detonation Medical Effects of a nuclear weapon detonation The Lifelong
More informationInfluence of the Age of Mice at Exposure to Radiation on. Life-shortening and Carcinogenesis
Influence of the Age of Mice at Exposure to Radiation on Life-shortening and Carcinogenesis SHUNSAKU SASAKI Division of Physiology and Pathology, National Institute of Radiological Sciences, 9-1, 4-Chome,
More informationCancer Risk Factors in Ontario. Other Radiation
Cancer Risk Factors in Ontario Other Radiation OTHer radiation risk factor/ exposure Radon-222 and decay products X-radiation, gamma radiation Cancer The context where high risks were reported Magnitude
More informationExtramedullary precursor T-lymphoblastic transformation of CML at presentation
Extramedullary precursor T-lymphoblastic transformation of CML at presentation Neerja Vajpayee, Constance Stein, Bernard Poeisz & Robert E. Hutchison Clinical History 30 year old man presented to the emergency
More informationLong-term Epidemiological Studies on Radiation Effects in A-bomb Survivors
Consultancy Meeting on Science, Technology and Society Perspectives on Nuclear Science, Radiation and Human Health: The International Perspective 23 May 2017 Hiroshima, Japan Long-term Epidemiological
More informationRadiation-induced induced Genomic Instability and Bystander Effects: implications for radiation leukaemogenesis
Radiation-induced induced Genomic Instability and Bystander Effects: implications for radiation leukaemogenesis University of Dundee Medical School Eric G Wright Professor of Experimental Haematology The
More informationChromosome Alterations in Oncogenesis
Haematology and Blood Transfusion Vol. 29 Modern Trends in Human Leukemia VI Edited by Neth, Gallo, Greaves, lanka Springer-Verlag Berlin Heidelberg 1985 Chromosome Alterations in Oncogenesis P. C. Nowell
More informationADx Bone Marrow Report. Patient Information Referring Physician Specimen Information
ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS
More informationoncogenes-and- tumour-suppressor-genes)
Special topics in tumor biochemistry oncogenes-and- tumour-suppressor-genes) Speaker: Prof. Jiunn-Jye Chuu E-Mail: jjchuu@mail.stust.edu.tw Genetic Basis of Cancer Cancer-causing mutations Disease of aging
More informationTRANSFORMATION OF CHRONIC MYELOGENOUS LEUKEMIA TO MULTIPLE MYELOMA: A CASE REPORT
TRANSFORMATION OF CHRONIC MYELOGENOUS LEUKEMIA TO MULTIPLE MYELOMA: A CASE REPORT A. Ghavamzadeh 1, K. Alimoghaddam 1, P. Mehdipour 2, R. Sharifian 1, G. Schwanitz 3 and A.R. Shamshiri 1 1) Hematology-Oncology
More informationMyeloproliferative Disorders - D Savage - 9 Jan 2002
Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2
More informationChildhood Leukemia Causes, Risk Factors, and Prevention
Childhood Leukemia Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for childhood
More informationYes I Can Site Report: The Radiation Effects Research Foundation in Hiroshima Report by Shari Yasin, McMaster University
Yes I Can Site Report: The Radiation Effects Research Foundation in Hiroshima Report by Shari Yasin, McMaster University 1. How did the RERF start? The Atomic Bomb Casualty Commission (ABCC), the predecessor
More informationChronic Myelogenous Leukemia (CML) Amplification of Rearranged c-abl Oncogenes in CML Blast Crisis
Breakpoints on Chromosomes 9 and 22 in Philadelphia Chromosome-positive Chronic Myelogenous Leukemia (CML) Amplification of Rearranged c-abl Oncogenes in CML Blast Crisis Steven J. Collins Department ofmedicine,
More informationChronic Myeloproliferative Disorders
Chronic Myeloproliferative Disorders Chronic Myeloproliferative Disorders Cytogenetic and Molecular Genetic Abnormalities Editor Barbara J. Bain, London 15 figures, 4 in color, and 18 tables, 2003 ABC
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationManaging Chronic Myeloid Leukemia
Concise Reference Managing Chronic Myeloid Leukemia Timothy P Hughes, David M Ross, Junia V Melo Extracted from Handbook of Chronic Myeloid Leukemia Published by Springer Healthcare Ltd, 236 Gray s Inn
More informationNuclear Weapons: The Final Pandemic Preventing Proliferation and Achieving Abolition London, October
Nuclear Weapons: The Final Pandemic Preventing Proliferation and Achieving Abolition London, October 3-4 2007 Sponsored by The Catastrophes and Conflict Forum, Royal Society of Medicine And International
More informationChronic Myelogenous Leukemia (Hematology) By DEISSEROTH READ ONLINE
Chronic Myelogenous Leukemia (Hematology) By DEISSEROTH READ ONLINE If searched for the ebook by DEISSEROTH Chronic Myelogenous Leukemia (Hematology) in pdf format, in that case you come on to correct
More informationCancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation
Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated
More informationGroup of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and
Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and / or peripheral blood Classified based on cell type
More informationTest Name Results Units Bio. Ref. Interval. Positive
LL - LL-ROHINI (NATIONAL REFERENCE 135091534 Age 36 Years Gender Female 1/9/2017 120000AM 1/9/2017 105316AM 2/9/2017 104147AM Ref By Final LEUKEMIA GENETIC ROFILE ANY SIX MARKERS, CR QUALITATIVE AML ETO
More informationTest Name Results Units Bio. Ref. Interval. Positive
LL - LL-ROHINI (NATIONAL REFERENCE 135091533 Age 28 Years Gender Male 1/9/2017 120000AM 1/9/2017 105415AM 4/9/2017 23858M Ref By Final LEUKEMIA DIAGNOSTIC COMREHENSIVE ROFILE, ANY 6 MARKERS t (1;19) (q23
More informationChronic Myelogenous Leukemia with e13a3 (b2a3) Type of BCR-ABL Transcript Having a DNA Breakpoint between ABL exons a2 and a3
American Journal of Hematology 74:268 272 (2003) Chronic Myelogenous Leukemia with e13a3 (b2a3) Type of BCR-ABL Transcript Having a DNA Breakpoint between ABL exons a2 and a3 Li-Gen Liu, 1,2 Hideo Tanaka,
More informationSWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017
LEUKEMIA FORMS The guidelines and figures below are specific to Leukemia studies. The information in this manual does NOT represent a complete set of required forms for any leukemia study. Please refer
More informationEpidemiologic Studies. The Carcinogenic Effects of Radiation: Experience from Recent Epidemiologic Studies. Types of Epidemiologic Studies
Division Of Cancer Epidemiology And Genetics Radiation Epidemiology Branch The Carcinogenic Effects of Radiation: Experience from Recent Epidemiologic Studies Elaine Ron Columbia University Radiation Course
More informationClassification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
More informationSignificance of Chromosome Changes in Hematological Disorders and Solid Tumors
Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome 3.3 X 10 9 DNA basepairs Estimated genetic constitution 30,000
More informationSignificance of Chromosome Changes in Hematological Disorders and Solid Tumors
Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome! Estimated genetic constitution! Size of average chromosome
More informationVariations in Chromosome Structure & Function. Ch. 8
Variations in Chromosome Structure & Function Ch. 8 1 INTRODUCTION! Genetic variation refers to differences between members of the same species or those of different species Allelic variations are due
More informationBrief Definitive Report
Brief Definitive Report T CELL RECEPTOR a CHAIN GENES ARE LOCATED ON CHROMOSOME 14 AT 14q11-14q12 IN HUMANS BY NICOLETTE CACCIA, GAIL A. P. BRUNS,* ILAN R. KIRSCH,* GREGORY F. HOLLIS,* VIRGINIA BERTNESS,*
More informationCitation Acta Medica Nagasakiensia. 1989, 34
NAOSITE: Nagasaki University's Ac Title Clinical Features of Adult T-cell L Author(s) Ichimaru, Michito Citation Acta Medica Nagasakiensia. 1989, 34 Issue Date 1989-03 URL http://hdl.handle.net/10069/17540
More informationThe Latest Update on Atomic-Bomb Survivor Studies
The Latest Update on Atomic-Bomb Survivor Studies Kotaro Ozasa, Yukiko Shimizu, Eric J Grant, Ritsu Sakata, Hiromi Sugiyama, Midori Soda, Kazunori Kodama Department of Epidemiology Radiation Effects Research
More informationHaematology Probes for Multiple Myeloma
Haematology Probes for Multiple Myeloma MULTIPLE MYELOMA Multiple myeloma (MM) is a plasma cell neoplasm, characterised by the accumulation of clonal plasma cells in the bone marrow and by very complex
More informationIntegrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University
Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic
More informationDetermination Differentiation. determinated precursor specialized cell
Biology of Cancer -Developmental Biology: Determination and Differentiation -Cell Cycle Regulation -Tumor genes: Proto-Oncogenes, Tumor supressor genes -Tumor-Progression -Example for Tumor-Progression:
More informationCase Report. Introduction. Mastocytosis associated with CML Hematopathology - March K. David Li 1,*, Xinjie Xu 1, and Anna P.
Mastocytosis associated with CML Hematopathology - March 2016 Case Report Systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) involving chronic myelogenous
More informationLeukine. Leukine (sargramostim) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.10.08 Subject: Leukine Page: 1 of 6 Last Review Date: March 13, 2014 Leukine Description Leukine (sargramostim)
More informationEpidemiological Evidence for Radiation-induced induced Circulatory Diseases Non-occupational occupational Exposure
Epidemiological Evidence for Radiation-induced induced Circulatory Diseases Non-occupational occupational Exposure Richard Wakeford Dalton Nuclear Institute, The University of Manchester, UK and Mark P
More information[COMPREHENSIVE GENETIC ASSAY PANEL ON
2014 SN GENELAB AND RESEARCH CENTER DR. SALIL VANIAWALA, PH.D [COMPREHENSIVE GENETIC ASSAY PANEL ON MYELOPROLIFERATIVE NEOPLASMS] SN Genelab presents one of the most comprehensive genetic assay panel for
More informationThe Epidemiology of Leukaemia and other Cancers in Childhood after Exposure to Ionising Radiation
IMPORTANT The following is a slide show presentation, presented by Dr. Richard Wakeford at the CHILDREN with LEUKAEMIA International Scientific Conference in London, September 2004. As such it is strictly
More informationDiagnostic challenge: Acute leukemia with biphenotypic blasts and BCR-ABL1 translocation
Case Study Diagnostic challenge: Acute leukemia with biphenotypic blasts and BCR-ABL1 translocation Ling Wang 1 and Xiangdong Xu 1,2,* 1 Department of Pathology, University of California, San Diego; 2
More informationMolecular Detection of BCR/ABL1 for the Diagnosis and Monitoring of CML
Molecular Detection of BCR/ABL1 for the Diagnosis and Monitoring of CML Imran Mirza, MD, MS, FRCPC Pathology & Laboratory Medicine Institute Sheikh Khalifa Medical City, Abu Dhabi, UAE. imirza@skmc.ae
More informationErnest Rutherford:
November 1895: Roentgen discovers x rays February 1896: Becquerel discovers radioactivity Ernest Rutherford 1898-99 Ernest Rutherford: 1898-99 The Electromagnetic Spectrum Interaction of Charged Particles
More informationCase #16: Diagnosis. T-Lymphoblastic lymphoma. But wait, there s more... A few weeks later the cytogenetics came back...
Case #16: Diagnosis T-Lymphoblastic lymphoma But wait, there s more... A few weeks later the cytogenetics came back... 46,XY t(8;13)(p12;q12)[12] Image courtesy of Dr. Xinyan Lu Further Studies RT-PCR
More informationCancer cytogenetics update 2005
Atlas of Genetics and Cytogenetics in Oncology and Haematology Cancer cytogenetics update 2005 Felix Mitelman Department of Clinical Genetics, University of Lund, Lund, Sweden March 2005 By January 2005,
More informationDifferentiation Ability of Peripheral Blood Cells from Patients with Acute Leukemia or Blast Crisis in Chronic Myelocytic Leukemia"
Differentiation Ability of Peripheral Blood Cells from Patients with Acute Leukemia or Blast Crisis in Chronic Myelocytic Leukemia" Hoelzer, D.,l, Harriss, E. B.l, Kurrle, E.l, Schmücker, H.l, Hellriegel,
More informationCase 089: Therapy Related t(8;21)(q22;q22) AML and
Case 089: Therapy Related t(8;21)(q22;q22) AML and SM-AHNMD ST Pullarkat 1, V Pullarkat 2, SH Kroft 3, CS Wilson 4, M Thein 5, WW Grody 1, and RK Brynes 5 1 UCLA, 2 City of Hope National Med Ctr, 3 Med
More informationFluorescence in-situ Hybridization (FISH) ETO(RUNX1T1)/AML1(RUNX1) or t(8;21)(q21.3;q22)
PML/RARA t(15;17) Translocation Assay Result : nuc ish(pml 2)(RARA 2)[200] : 200/200(100%) interphase nuclei show normal 2O 2G signals for PML/RARA : is Negative for t(15;17)(q22;q21.1) 2 Orange 2 Green
More informationDynamics of Chronic Myeloid Leukemia Supplementary Online Material
Dynamics of Chronic Myeloid Leukemia Supplementary Online Material Franziska Michor, Timothy P. Hughes, Yoh Iwasa, Susan Branford, Neil P. Shah, Charles L. Sawyers & Martin A. Nowak The basic model. Our
More informationCytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome
Ann Hematol (2013) 92:185 189 DOI 10.1007/s00277-012-1598-8 ORIGINAL ARTICLE Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia
More informationHematologic and cytogenetic responses of Imatinib Mesylate and significance of Sokal score in chronic myeloid leukemia patients
ORIGINAL ALBANIAN MEDICAL RESEARCH JOURNAL Hematologic and cytogenetic responses of Imatinib Mesylate and significance of Sokal score in chronic myeloid leukemia patients Dorina Roko 1, Anila Babameto-Laku
More informationSecond primary cancers in adults after radiotherapy an epidemiological review
Second primary cancers in adults after radiotherapy an epidemiological review Article 31 Group meeting Radiation induced long-term health effects after medical exposure Luxembourg, 19 November 2013 Mark
More informationTest Name Results Units Bio. Ref. Interval. Positive
Lab No 135091548 Age 35 Years Gender Female 1/9/2017 120000AM 1/9/2017 103420AM 4/9/2017 23753M Ref By Dr UNKNWON Final Test Results Units Bio Ref Interval LEUKEMIA DIAGNOSTIC COMREHENSIVE ROFILE 3 t (1;19)
More informationNEUTRON RADIATION. 1. Exposure Data. 2. Cancer in Humans
NEUTRON RADIATION Neutrons were considered by a previous IARC Working Group in 1999 (IARC, 2000). Since that time, new data have become available, these have been incorporated into the Monograph, and taken
More informationCytogenetic and Molecular Evaluation in Myelodysplastic Syndrome and in Acute and Chronic Leukemia
Cytogenetic and Molecular Evaluation in Myelodysplastic Syndrome and in Acute and Chronic Leukemia Peter R. Papenhausen, PhD, Lynn C. Moscinski, MD, and Cameron G. Binnie, PhD The advent of molecular cytogenetic
More informationEVI-1 oncogene expression predicts survival in chronic phase CML patients resistant to imatinib
EVI-1 oncogene expression predicts survival in chronic phase CML patients resistant to imatinib Mustafa Daghistani Department of Haematology, Imperial College London at Hammersmith Hospital, Du Cane Road,
More informationOn the Incidence of Leukemias in Hiroshima During. the Past Fifteen Years from 1946 to 1960* WATANABE Susumu **
On the Incidence of Leukemias in Hiroshima During the Past Fifteen Years from 1946 to 1960* WATANABE Susumu ** (Received in September 1961) We have followed up the incidence of leukemias in Hiroshima,
More informationSTUDIES OF LOW-DOSE RADIATION AND CANCER. E. Lubin
STUDIES OF LOW-DOSE RADIATION AND CANCER E. Lubin 1 RELEVANT DATA BEIR VII 2006 UNSCEAR 2000 ICRP PIERCE D. PRESTON DL Japanese survivors. CARDIS E. IARC occupational exposure. BRENNER D. CT exposure and
More informationMicroRNAs: the primary cause or a determinant of progression in leukemia?
MicroRNAs: the primary cause or a determinant of progression in leukemia? The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More informationMyelodysplastic syndrome (MDS) & Myeloproliferative neoplasms
Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)
More informationCYTOGENETIC STUDY OF 50 DE NOVO CASES OF ANLL FROM ARGENTINA. Susana Acevedo, Irma Slavutsky, Gabriela Andreoli, Irene Larripa
original paper Haematologica 1994; 79:40-5 CYTOGENETIC STUDY OF 50 DE NOVO CASES OF ANLL FROM ARGENTINA Susana Acevedo, Irma Slavutsky, Gabriela Andreoli, Irene Larripa Departamento de Genética, División
More informationNeoplastic proliferation arising from white blood cells. Introductory remarks. Classification
Neoplastic proliferation arising from white blood cells Lymphoproliferative and myeloproliferative diseases and syndromes Oliver Rácz, 2012-2017 1 Introductory remarks Leukemia and lymphoma are old descriptive
More informationIonizing Radiation. Nuclear Medicine
Ionizing Radiation Nuclear Medicine Somatic Deterministic Effect Erythema Somatic Stochastic Effect Leukemia Genetic Effects DNA BIOLOGICAL EFFECTS OF IONIZING RADIATION ON TISSUES, ORGANS AND SYSTEMS
More informationMethylation status of SOCS1 and SOCS3 in BCR-ABL negative and. JAK2V617F negative chronic myeloproliferative disorders.
Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative disorders. To the Editor BCR-ABL negative Chronic Myeloproliferative Disorders (s) are a heterogeneous
More informationscreening procedures Disease resistant to full-dose imatinib ( 600 mg/day) or intolerant to any dose of imatinib
Table S1. Study inclusion and exclusion criteria Inclusion criteria Aged 18 years Signed and dated informed consent form prior to protocol-specific screening procedures Cytogenetic- or PCR-based diagnosis
More informationHeme 9 Myeloid neoplasms
Heme 9 Myeloid neoplasms The minimum number of blasts to diagnose acute myeloid leukemia is 5% 10% 20% 50% 80% AML with the best prognosis is AML with recurrent cytogenetic abnormality AML with myelodysplasia
More informationMyeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:
Myeloid neoplasms Note: Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories: 1. AML : Acute myeloid leukemia(stem cell with myeloid
More informationCancer and Tyrosine Kinase Inhibition
Cancer and Tyrosine Kinase Inhibition 1 Motivation (1) In first world countries cancer is the second most common cause of death after cardiovascular diseases. For most tumors, treatment is limited to surgery,
More informationCore Concepts in Radiation Exposure 4/10/2015. Ionizing Radiation, Cancer, and. James Seward, MD MPP
Ionizing Radiation, Cancer, and Causation James P. Seward, MD MPP FACOEM Clinical Professor of Medicine, UCSF American Occupational Health Conf May 4, 2015 Ionizing Radiation, Cancer, and Causation James
More informationEstimates of Risks LONG-TERM LOW DOSE EFFECTS OF IONIZING RADIATION
Estimates of Risks LONG-TERM LOW DOSE EFFECTS OF IONIZING RADIATION Low Level Radiation Exposure Single exposure of 10 rad or less Larger exposures delivered over periods of days or longer (low dose
More informationTherapy-related MDS/AML with KMT2A (MLL) Rearrangement Following Therapy for APL Case 0328
Therapy-related MDS/AML with KMT2A (MLL) Rearrangement Following Therapy for APL Case 0328 Kenneth N. Holder, Leslie J. Greebon, Gopalrao Velagaleti, Hongxin Fan, Russell A. Higgins Initial Case: Clinical
More informationHow to detect the rare BCR ABL (e14a3) transcript: A case report and literature review
ONCOLOGY LETTERS 14: 5619-5623, 2017 How to detect the rare BCR ABL (e14a3) transcript: A case report and literature review LIN HUI HU, LIAN FANG PU, DONG DONG YANG, CUI ZHANG, HUI PING WANG, YANG YANG
More informationRole of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
More informationBIT 120. Copy of Cancer/HIV Lecture
BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations
More information